SSR-180711 is a drug that acts as a potent and selective partial agonist for the α7 subtype of neural nicotinic acetylcholine receptors. In animal studies it shows nootropic effects and may be useful in the treatment of schizophrenia.
This page contains content from the copyrighted Wikipedia article "SSR-180711"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
